The Protective Effect of Omeprazole on Vancomycin Cytotoxicity in HK‐2 Cells and Renal Injury in Rats
<b>Objective:</b> Vancomycin is the first-line treatment for <i>MRSA</i> infection, and high plasma concentration can cause nephrotoxicity. The aim of the study was to determine the correlation between intracellular vancomycin concentration and HK-2 cytotoxicity and explore omeprazole's protective effect. <b>Methods:</b> The activity of HK-2 cells was detected, HPLC method was established and verified, and the vancomycin concentrations in the intracellular and extracellular fluids of HK-2 cells were determined. Western blot was used to investigate the expressions of P-glycoprotein (P-gp) and organic cation transporter-2 (OCT-2) transporters. Blood urea nitrogen (BUN), blood creatinine (CRE), <i>N</i>-acetyl-<i>β</i>-d-glucosaminidase (NAG), and kidney injury molecule-1 (KIM-1) of rats in the vancomycin group and drug combination group were determined; the kidney tissue pathological examination and renal injury score were performed. <b>Results:</b> The HPLC method met the requirements for biological sample determination. The cytotoxicity of vancomycin in HK-2 cells was concentration-dependent within 1-20 mg/mL; omeprazole could reduce the intracellular accumulation of vancomycin. Western blot assay confirmed that omeprazole increased intracellular vancomycin efflux by upregulating P-gp expression and inhibited its intracellular transport by downregulating OCT-2 expression. Vancomycin increased renal function indicators and pathological injury score in rats, while there was a significant decrease in the drug combination group, together with alleviated renal tissue damage. <b>Conclusion:</b> Intracellular accumulation of vancomycin can cause damage to HK-2 cells and induce vancomycin-related nephrotoxicity in rats. Omeprazole can reduce vancomycin cytotoxicity by upregulating P-gp expression and inhibiting OCT-2 expression.
Authors
- Zhiqing Zhang (ORCID: https://orcid.org/0000-0002-9306-3267)
- Xikun Wu (ORCID: https://orcid.org/0000-0002-8986-4600)
- Yakun Zhang (ORCID: https://orcid.org/0000-0001-9854-5620)
- Jiaxu Wu (ORCID: https://orcid.org/0000-0002-5978-6963)
- Wenli Li (ORCID: https://orcid.org/0000-0003-1598-3217)
Institutions
- Hebei Medical University (CN)
- Second Hospital of Hebei Medical University (CN)
Publication Details
- Journal
- BioMed Research International
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1155/bmri/3520935
- Citations
- 1
- Primary Topic
- Antibiotics Pharmacokinetics and Efficacy
- Type
- article
- Field-Weighted Citation Impact
- 1.39
Funders
- Health Commission of Hebei Province